openPR Logo
Press release

Drug Delivery Devices Market Size, Challenges, Growth, Future Potential Of Industry 2026

07-30-2020 05:54 PM CET | Health & Medicine

Press release from: Allied Market Research

Drug Delivery Devices Market

Drug Delivery Devices Market

Drugs are used to improve health and prolong life. However, the drug can be swallowed, absorbed, inhaled, taken through the skin, and in a variety of ways, including intravenous injections. For this, drug delivery devices have been developed, which are special tools for delivering therapeutic agents through certain types of devices.

The drug delivery device market size reached $19 billion in 2018 and is expected to reach $267 billion by 2026, with an annual CAGR of 4.3% from 2019 to 2026.

know more: https://www.alliedmarketresearch.com/drug-delivery-devices-market-A06095

The drug delivery system controls the rate at which the drug is released and the location of the body from which the drug is released. In addition, these devices are used in the treatment of various chronic diseases. In addition, drug delivery methods have changed dramatically over the past few decades and drug delivery technology is expected to change in the near future.

Click here to access the free sample report: https://www.alliedmarketresearch.com/request-sample/6460

The main contributors to the growth of the drug delivery device market include increased prevalence of chronic diseases worldwide. In addition, other factors driving the growth of the drug delivery device market include a surge in the elderly population worldwide and increased adoption of biologics worldwide. However, strict government regulations regarding the launch of new drug delivery devices hinder the growth of the drug delivery device market. Conversely, the high growth potential of developing countries is expected to provide profitable opportunities during the forecast period.

The drug delivery device market size provides a detailed assessment of the market by studying based on device type, route of administration, and region. Depending on the device type, it is divided into smart pills, inhalers, drug elution stents, safety syringes, implantable drug delivery devices, and transdermal patches. Depending on the route of administration, branches to hospitals and diagnostic centers, outpatient surgery centers and clinics. By region, North America (USA, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain and other Europe), Asia Pacific (China, Japan, India, Australia, Korea, and the rest of Asia Pacific) and LAMEA ( Brazil, South Africa and the rest of LAMEA).

Inhalers and nebulizers have gained a major share of the drug delivery market in 2018 by product and are expected to continue this trend during the forecast period due to factors such as a surge in respiratory diseases like asthma worldwide. In addition, other factors, such as increased awareness about the use of inhalers and nebulizers in the treatment of respiratory diseases, are other factors that promote the growth of the drug delivery device market. In addition, the smart pill segment is expected to have the fastest CAGR due to the benefits associated with the use of these devices. For example, smart pills have made it possible to monitor the results of various drug administrations that greatly support different stages of drug development, such as drug candidate profiling, drug candidate selection, and accelerated development of new drugs. In addition, this new technology provides an important opportunity for the healthcare industry to take advantage of modern digital innovation and take a leading position in the future healthcare sector.

Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/6460

The main results of the study:
• Inhalers and nebulizers accounted for more than a third of the global market for drug delivery devices in 2018.
• End-user hospital and diagnostic center sectors are expected to grow to the highest CAGR during the forecast period.
• The device type transdermal patch segment occupied more than a third of the drug delivery device market in 2018.
• The Asia Pacific region is expected to grow at the highest rate during the analysis period, followed by LAMEA.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Delivery Devices Market Size, Challenges, Growth, Future Potential Of Industry 2026 here

News-ID: 2100080 • Views: 217

More Releases from Allied Market Research

Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning